SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Chinese Regulators Approved Novartis' Mayzent to Treat Relapsing MS in Adults

Benzinga · 05/09/2020 13:00